Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81802182, 81802182)
President Foundation of Nanfang Hospital, Southern Medical University (2020C027, 2020C027, 2020C027, 2020C027)
Postdoctoral Science Foundation of China (2021M701635, 2021M701635, 2021M701635, 2021M701635)
- License Information
-
More Information
Article History
Received: 7 September 2021
Accepted: 27 January 2022
First Online: 17 February 2022
Declarations
:
: The data of GSE111016 was extracted from a Singapore sarcopenia study, which was approved by the National Healthcare Group Domain-Specific Research Board (NHG DSRB)(reference number 2014/01304), and each participant gave written informed consent. The data of GSE111006 was extracted from a Hertfordshire sarcopenia study, which was approved by the Hertfordshire Research Ethics Committee approval number 07/Q0204/68), and each participant gave written informed consent. The data of GSE111010 was extracted from a Jamaica sarcopenia study, which was approved by the University of West Indies Research Ethics Committee (approval number 180,10/11), and each participant gave written informed consent. This current study is a network integration analysis based on published data. The human related data we used, such as muscle tissue sequencing results, were carefully reviewed and in accordance with the Declaration of Helsinki. This data analysis study protocol has been approved by the ethics board of Nanfang Hospital, Southern Medical University.
: Not applicable.
: The authors declare that there is no conflict of interest regarding the publication of this paper.
